Carlson Capital Management Bristol Myers Squibb CO Transaction History

Carlson Capital Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 18, 2022	SELL	$72.62 - $79.98 $236,813 - $260,814	-3,261 Closed	0 $0
Q1 2022 May 24, 2022	BUY	$61.48 - $73.72 $200,486 - $240,400	3,261 New	3,261 $238,000
Q2 2020 Jul 13, 2020	SELL	$54.82 - $64.09 $245,812 - $287,379	-4,484 Closed	0 $0
Q1 2020 Apr 27, 2020	BUY	$46.4 - $67.43 $208,057 - $302,356	4,484 New	4,484 $279,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Carlson Capital Management, based on Form 13F filings with the SEC.

Stay updated on Carlson Capital Management with notifications on news.